Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance

Por Nakatsuka, Katsuhisa, Atsukawa, Masanori, Shimizu, Masumi, Takahashi, Hidemi, Kawamoto, Chiaki
Publicado no World J Hepatol (2015)

Ribavirin modulates the conversion of human CD4(+) CD25(−) T cell to CD4(+) CD25(+) FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell

Por Kobayashi, Tamaki, Nakatsuka, Katsuhisa, Shimizu, Masumi, Tamura, Hideto, Shinya, Eiji, Atsukawa, Masanori, Harimoto, Hirotomo, Takahashi, Hidemi, Sakamoto, Choitsu
Publicado em 2012

Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients

Por Nakagawa, Ai, Atsukawa, Masanori, Tsubota, Akihito, Kondo, Chisa, Okubo, Tomomi, Arai, Taeang, Itokawa, Norio, Narahara, Yoshiyuki, Iwakiri, Katsuhiko
Publicado no World J Gastroenterol (2016)

Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients

Por Abe, Hiroshi, Tsubota, Akihito, Shimada, Noritomo, Atsukawa, Masanori, Kato, Keizo, Takaguchi, Koichi, Asano, Toru, Chuganji, Yoshimichi, Sakamoto, Choitsu, Toyoda, Hidenori, Kumada, Takashi, Ide, Tatsuya, Sata, Michio, Aizawa, Yoshio
Publicado em 2014

Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study

Por Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Kondo, Chisa, Itokawa, Norio, Nakagawa, Ai, Hashimoto, Satomi, Fukuda, Takeshi, Matsushita, Yoko, Kidokoro, Hideko, Narahara, Yoshiyuki, Nakatsuka, Katsuhisa, Iwakiri, Katsuhiko, Kawamoto, Chiaki, Sakamoto, Choitsu
Publicado em 2013

Influencing factors on serum 25-hydroxyvitamin D(3) levels in Japanese chronic hepatitis C patients

Por Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Yoshizawa, Kai, Abe, Hiroshi, Asano, Toru, Ohkubo, Yusuke, Araki, Masahiro, Ikegami, Tadashi, Kondo, Chisa, Itokawa, Norio, Nakagawa, Ai, Arai, Taeang, Matsushita, Yoko, Nakatsuka, Katsuhisa, Furihata, Tomomi, Chuganji, Yoshimichi, Matsuzaki, Yasushi, Aizawa, Yoshio, Iwakiri, Katsuhiko
Publicado no BMC Infect Dis (2015)

Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Por Kumagai, Erina, Mano, Yohei, Yoshio, Sachiyo, Shoji, Hirotaka, Sugiyama, Masaya, Korenaga, Masaaki, Ishida, Tsuyoshi, Arai, Taeang, Itokawa, Norio, Atsukawa, Masanori, Hyogo, Hideyuki, Chayama, Kazuaki, Ohashi, Tomohiko, Ito, Kiyoaki, Yoneda, Masashi, Kawaguchi, Takumi, Torimura, Takuji, Nozaki, Yuichi, Watanabe, Sumio, Mizokami, Masashi, Kanto, Tatsuya
Publicado no Sci Rep (2016)

Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Por Shoji, Hirotaka, Yoshio, Sachiyo, Mano, Yohei, Kumagai, Erina, Sugiyama, Masaya, Korenaga, Masaaki, Arai, Taeang, Itokawa, Norio, Atsukawa, Masanori, Aikata, Hiroshi, Hyogo, Hideyuki, Chayama, Kazuaki, Ohashi, Tomohiko, Ito, Kiyoaki, Yoneda, Masashi, Nozaki, Yuichi, Kawaguchi, Takumi, Torimura, Takuji, Abe, Masanori, Hiasa, Yoichi, Fukai, Moto, Kamiyama, Toshiya, Taketomi, Akinobu, Mizokami, Masashi, Kanto, Tatsuya
Publicado no Sci Rep (2016)